IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 251 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,348 | -36.3% | 19,870 | -29.6% | 0.04% | -53.4% |
| Q2 2023 | $300,261 | +6.7% | 28,220 | +5.5% | 0.09% | -2.2% |
| Q1 2023 | $281,410 | -14.3% | 26,750 | +1.0% | 0.09% | -17.4% |
| Q4 2022 | $328,298 | +35.7% | 26,497 | +13.3% | 0.11% | -8.4% |
| Q3 2022 | $242,000 | +8.0% | 23,387 | +20.5% | 0.12% | -14.4% |
| Q2 2022 | $224,000 | +23.1% | 19,409 | +33.8% | 0.14% | +52.7% |
| Q1 2022 | $182,000 | +15.2% | 14,504 | +7.4% | 0.09% | +24.7% |
| Q4 2021 | $158,000 | +364.7% | 13,503 | +422.6% | 0.07% | +231.8% |
| Q3 2021 | $34,000 | -50.0% | 2,584 | -51.4% | 0.02% | -48.8% |
| Q2 2021 | $68,000 | +223.8% | 5,316 | +183.2% | 0.04% | +26.5% |
| Q1 2021 | $21,000 | – | 1,877 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $172,422,800 | 22.05% |
| 13D Management LLC | 533,562 | $5,613,073 | 2.85% |
| Quantedge Capital Pte Ltd | 541,200 | $5,693,424 | 2.22% |
| Price Jennifer C. | 520,000 | $5,470,400 | 1.74% |
| Tamarack Advisers, LP | 210,000 | $2,209,200 | 0.81% |
| Intrinsic Value Partners, LLC | 51,605 | $542,885 | 0.73% |
| Brown Capital Management | 3,933,933 | $41,384,975 | 0.62% |
| Old West Investment Management, LLC | 75,219 | $791,303 | 0.43% |
| EMC Capital Management | 43,315 | $456 | 0.38% |
| Hillsdale Investment Management Inc. | 420,617 | $4,424,891 | 0.38% |